Other News

Affluent Medical Announces the Launch of the MINERVA First-In-Human Clinical Study of EPYGON

EPYGON is the first native-like transcatheter mitral valve replacement technology aiming at achieving better clinical outcomes The Austrian Competent Authority has granted authorization to start patient enrollment at Vienna General Hospital (AKH) The EPYGON valve has the potential to become a new paradigm in the treatment of functional mitral regurgitation […]

BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering

Westport, CT, June 24, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 2,187,500 shares of the Company’s common stock, at a purchase price of $8.00 […]

Windtree Announces Initial European Trial Sites Activated in AEROSURF® Bridging Study and a Collaboration for a Concomitant Independent Cerebral Physiology Study

WARRINGTON, Pa., June 24, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that all initial European trial sites are active and enrolling or able to enroll patients into […]

BAROSTIM™ NEO Associated with Very High Responder Rates in Women

BeAT-HF Trial Results Presented as Late-Breaking Clinical Science at ESC Heart Failure 2020 Meeting MINNEAPOLIS, June 23, 2020 /PRNewswire/ — CVRx, Inc., a private medical device company, announced new BeAT-HF trial results from late-breaking clinical science presented virtually at the European Society of Cardiology Heart Failure 2020 Scientific Sessions. The BAROSTIM NEO […]

preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment

Pioneering technology is designed to address Acute Decompensated Heart Failure ST. PAUL, Minn., June 23, 2020/PRNewswire/ — preCARDIA, Inc., has announced that the company’s catheter based system for treating volume overload in patients with acutely decompensated heart failure (ADHF) has been designated for the Breakthrough Devices Program by the U.S. […]

Ablacon, Inc. Announces the Formation of Scientific Advisory Board

Scientific advisory board composed of thought leaders in electrophysiology and treatment of atrial fibrillation MENLO PARK, Calif., June 23, 2020 /PRNewswire/ — Ablacon, Inc., an Ajax Health-backed company, announced today the formation of its Scientific Advisory Board (SAB). The SAB will be composed of four internationally recognized thought leaders in the field of electrophysiology […]

Bendit Technologies Announces Senior Management Appointments

Richard Cappetta has been appointed Chairman of the Board and Yossi Mazel will be the new CEO TEL AVIV, Israel, June 23, 2020 /PRNewswire/ — Bendit Technologies, an industry leader in the development of steerable microcatheters, announced today that Richard Cappetta has been appointed as its Chairman of the Board. Together with this appointment, it was announced that Yossi […]

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] […]